Contract V797D50597
Roche Diabetes Care Inc · Department Of Veterans Affairs · April 28, 2025
Roche Diabetes Care Inc was awarded a federal contract by Department Of Veterans Affairs on April 28, 2025 for an undisclosed amount of work in in-vitro diagnostic substance manufacturing. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 18, 2026. If all options are exercised, the contract could reach $325.07 million.
Contract details
- PIID
- V797D50597
- Award type
- Fss
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
- First action
- April 28, 2025
- Latest action
- March 18, 2026
Description
CONTRACT CANCEL
Modification timeline
-
March 18, 2026Mod P00044 · Supplemental Agreement For Work Within Scope$0
-
December 27, 2025Mod P00043 · Supplemental Agreement For Work Within Scope2026 SUBPLAN$0
-
April 28, 2025Mod P00042$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Biomerieux Inc | Department Of Veterans Affairs | July 2, 2026 | $845.5K |
| Abbott Laboratories Inc. | Department Of Veterans Affairs | July 2, 2026 | $11.0K |
| Tosoh Bioscience, Inc. | Department Of Veterans Affairs | July 2, 2026 | $1.2K |
| Tosoh Bioscience, Inc. | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Abbott Molecular Inc. | Department Of Veterans Affairs | July 1, 2026 | $729.8K |
| Cepheid | Department Of Veterans Affairs | July 1, 2026 | $305.8K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract V797D50597?
Contract V797D50597 is a federal contract awarded to Roche Diabetes Care Inc by Department Of Veterans Affairs on April 28, 2025 for an undisclosed amount of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 2 times since the base award.
Who won contract V797D50597?
Roche Diabetes Care Inc won contract V797D50597 from Department Of Veterans Affairs.
How much is contract V797D50597 worth?
Contract V797D50597 has obligated $0 to date but carries a potential ceiling of $325.07 million if fully funded and all options are exercised.